Western Australia-based gold miner expects resource growth to continue
Medusa Mining has increased the resource estimate for its Co-O gold mine in the Philippines to 1.38m oz.
According to the Western Australia-based company, this new figure for indicated and inferred resources together represents a 15% increase over six months and a 60% gain over a year. The average grade is a respectable 10.8 grammes of gold per tonne of ore.
The stronger category of indicated resources is 25.6% up in six months to 603,000 oz at 15 grammes a tonne, with the more speculative inferred resources category showing 777,000 oz at 8.9 grammes a tonne. Managing director Geoff Davies says ‘we expect resource growth to continue, especially to the east of the mine, as more drilling is undertaken’.
Highlighted by Growth Company Investor at 27p three years ago and again at 48p last January, Medusa shares have now reached 125.5p. Hold on for now.
Market cap: £212m
PE Forecast: 5.7
Share price: 125.5p
More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.
Advertisement
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.
Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.
GW Pharmaceuticals has won approval from Health Canada for its cannabis-based Sativex product to treat spasticity caused by Multiple Sclerosis.